Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL8201466 | 0.96 | — | — | |
| Trifluoroacetic Acid SCHEMBL225730 | 0.96 | CA4 (0.36) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL28576102 | 0.96 | CA4 (0.36) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL8066424 | 0.93 | CA4 (0.41) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL27900785 | 0.93 | CA4 (0.35) | CA4CA2CASP1 | |
| Trifluoroacetic Acid SCHEMBL4342494 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL108536 | 0.92 | — | — | |
| Trifluoroacetic Acid SCHEMBL282294 | 0.92 | — | — | |
| Trifluoroacetic Acid SCHEMBL20569660 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL20541013 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1554 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747238-A1 | PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS | Sanofi (FR) | 2026-05-27 | — | — | EP | claimed |
| US-12599138-B2 | Cellulosic fibers comprising internally dispersed cuprous oxide nanoparticles | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2026-04-14 | — | — | US | claimed |
| EP-4688726-A1 | PROCESS FOR THE PREPARATION OF AMINE INTERMEDIATES | Adama Agan Ltd. (IL) | 2026-02-11 | — | — | EP | claimed |
| CN-120136859-A | Binaphthyl structure-assisted chiral pyridine oxazoline ligand, preparation method and application thereof | 华东理工大学 | 2025-06-13 | — | — | CN | claimed |
| CN-116947709-B | Synthesis method of beta-arylvinyl sulfonyl fluoride compound | 江南大学 | 2025-06-03 | — | — | CN | claimed |
| EP-4559903-A1 | PRODUCTION METHOD FOR TAFAMIDIS OR SALT THEREOF | Shiratori Pharmaceutical Co., Ltd. (JP) | 2025-05-28 | — | — | EP | claimed |
| US-12288878-B2 | Ionic liquids in lithium ion batteries | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2025-04-29 | — | — | US | claimed |
| CN-119823017-A | 2-Sulfonylamino pyrrole derivative and preparation method thereof | 广东医科大学 | 2025-04-15 | — | — | CN | claimed |
| CN-119707789-A | Stable ketene imine pyridinium salt and preparation method thereof | 广东医科大学 | 2025-03-28 | — | — | CN | claimed |
| WO-2025061927-A1 | METHOD OF MAKING LANIFIBRANOR | INVENTIVA (FR) | 2025-03-27 | — | — | WO | claimed |
| EP-0989419-A1 | Composition for near infrared absorption filter, and near infrared absorption filter produced using said composition | NISSHINBO INDUSTRIES, INC. (JP) | 2000-03-29 | — | — | EP | claimed |
| US-5939382-A | PYRIDINE-BORANE AS A REDUCING AGENT | ELI LILLY AND COMPANY (US) | 1999-08-17 | — | — | US | claimed |
| EP-0884590-A1 | Carbon monoxide sensors with controlled response threshold | QUANTUM GROUP (US) | 1998-12-16 | — | — | EP | claimed |
| EP-0779975-A4 | PHOTON ABSORBING BIODERIVED ORGANOMETALLIC CARBON MONOXIDE SENSORS | QUANTUM GROUP INC (US) | 1997-12-29 | — | — | EP | claimed |
| CN-1162355-A | Photon absorbing bioderived organometallic carbon monoxide sensitive element | QUANTUM GROUP INC (US) | 1997-10-15 | — | — | CN | claimed |
| EP-0779975-A1 | PHOTON ABSORBING BIODERIVED ORGANOMETALLIC CARBON MONOXIDE SENSORS | QUANTUM GROUP INC. (US) | 1997-06-25 | — | — | EP | claimed |
| WO-1996007091-A1 | PHOTON ABSORBING BIODERIVED ORGANOMETALLIC CARBON MONOXIDE SENSORS | QUANTUM GROUP, INC. (US) | 1996-03-07 | — | — | WO | claimed |
| US-5100871-A | Method for preparing rare earth-barium-cuprate pre-ceramic resins and superconductive materials prepared therefrom | GENERAL ATOMICS (US) | 1992-03-31 | — | — | US | claimed |
| US-4043934-A | Catalyst and method for oxidizing reducing gases | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1977-08-23 | — | — | US | claimed |
| US-4005128-A | FROM CARBON MONOXIDE AND ALCOHOL, METAL SALT CATALYST | ATLANTIC RICHFIELD COMPANY (US) | 1977-01-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12599138-B2 | Cellulosic fibers comprising internally dispersed cuprous oxide nanoparticles | CROCC, CNBP, SOD1 | CA4 520/4885CA2 287/4885CA1 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.